Bayer Yakuhin Launches Fosrenol Chewable Tablet In Japan
This article was originally published in PharmAsia News
Executive Summary
Bayer Yakuhin launched March 11 Fosrenol (lanthanum carbonate) chewable tablets in Japan. Indicated to reduce phosphate levels in patients with end-stage renal disease, Fesrenol is a phosphorus binder that works to absorb the phosphorus in foods before it can be absorbed into body. The excess phosphorus is then removed from body as waste. Bayer expects to reach ¥10.5 billion in sales in its peak, which is 10 years after the launch. (Click here for more - Japanese language